Lancashire (LRE) Competitors

Mediclinic International (LON:MDC) and Lancashire (LON:LRE) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, community ranking, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and valuation.

Do institutionals and insiders hold more shares of MDC or LRE?

39.2% of Mediclinic International shares are owned by institutional investors. Comparatively, 60.5% of Lancashire shares are owned by institutional investors. 48.9% of Mediclinic International shares are owned by insiders. Comparatively, 0.6% of Lancashire shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media refer more to MDC or LRE?

In the previous week, Mediclinic International's average media sentiment score of 0.00 equaled Lancashire'saverage media sentiment score.

Company	Overall Sentiment
Mediclinic International	Neutral
Lancashire	Neutral

Does the MarketBeat Community believe in MDC or LRE?

Lancashire received 115 more outperform votes than Mediclinic International when rated by MarketBeat users. However, 57.33% of users gave Mediclinic International an outperform vote while only 44.53% of users gave Lancashire an outperform vote.

Company	Underperform	Outperform
Mediclinic International	Outperform Votes 219 57.33%	Underperform Votes 163 42.67%
Lancashire	Outperform Votes 334 44.53%	Underperform Votes 416 55.47%

Do analysts prefer MDC or LRE?

Lancashire has a consensus price target of GBX 781, suggesting a potential upside of 19.06%. Given Lancashire's stronger consensus rating and higher possible upside, analysts clearly believe Lancashire is more favorable than Mediclinic International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mediclinic International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lancashire	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Is MDC or LRE a better dividend stock?

Mediclinic International pays an annual dividend of GBX 3 per share. Lancashire pays an annual dividend of GBX 18 per share and has a dividend yield of 2.7%. Mediclinic International pays out 1,304.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Lancashire pays out 1,592.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Which has more risk and volatility, MDC or LRE?

Mediclinic International has a beta of 0.42, meaning that its share price is 58% less volatile than the S&P 500. Comparatively, Lancashire has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500.

Which has better valuation and earnings, MDC or LRE?

Lancashire has lower revenue, but higher earnings than Mediclinic International. Mediclinic International is trading at a lower price-to-earnings ratio than Lancashire, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mediclinic International	£3.38B	0.00	£169M	£0.23	N/A
Lancashire	£1.36B	1.16	£363.10M	£1.13	580.48

Is MDC or LRE more profitable?

Lancashire has a net margin of 26.72% compared to Mediclinic International's net margin of 4.99%. Lancashire's return on equity of 23.96% beat Mediclinic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mediclinic International	4.99%	5.50%	2.30%
Lancashire	26.72%	23.96%	6.75%

Summary

Lancashire beats Mediclinic International on 12 of the 17 factors compared between the two stocks.